Literature DB >> 7543779

IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro.

P Petzelbauer1, C A Watson, S E Pfau, J S Pober.   

Abstract

It has been established that IL-8 triggers angiogenesis in vivo, but this effect may be mediated either by IL-8-recruited leukocytes or by direct actions of IL-8 upon endothelial cells (EC). We have approached this question by examining interactions of recombinant human IL-8 with cultured large vessel and microvascular human EC. We are unable to detect specific IL-8 binding to cultured human umbilical vein endothelial cells (HUVEC) or leukocyte-like IL-8 receptor mRNA expression by either cultured HUVEC or human dermal microvascular endothelial cells (DMEC). We find no alteration of cytoplasmic calcium concentration ([Ca2+]i) in either cell type in response to IL-8 treatment. Finally, we find no IL-8-induced change in EC proliferative rates in the presence or absence of endothelial cell growth factor. Our data favour an indirect action for IL-8 as an angiogenic factor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543779     DOI: 10.1006/cyto.1995.0031

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  22 in total

1.  Effects of thalidomide on parameters involved in angiogenesis: an in vitro study.

Authors:  M Gelati; E Corsini; S Frigerio; B Pollo; G Broggi; D Croci; A Silvani; A Boiardi; A Salmaggi
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

2.  The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.

Authors:  Hans R Lüttichau
Journal:  J Biol Chem       Date:  2009-12-31       Impact factor: 5.157

3.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

4.  CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.

Authors:  X W Zhang; Q Liu; Y Wang; H Thorlacius
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

5.  Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice.

Authors:  Yusheng Wang; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

6.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

Authors:  R Salcedo; K Wasserman; H A Young; M C Grimm; O M Howard; M R Anver; H K Kleinman; W J Murphy; J J Oppenheim
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Phenotypic and functional characteristics of tumour-derived microvascular endothelial cells.

Authors:  G Alessandri; R G Chirivi; S Fiorentini; R Dossi; S Bonardelli; S M Giulini; G Zanetta; F Landoni; P P Graziotti; A Turano; A Caruso; L Zardi; R Giavazzi; M R Bani
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 8.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

9.  Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration.

Authors:  P Hillyer; E Mordelet; G Flynn; D Male
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

10.  Mast-cell-dependent secretion of CXC chemokines regulates ischemia-reperfusion-induced leukocyte recruitment in the colon.

Authors:  Stefan Santen; Yusheng Wang; Michael D Menger; Bengt Jeppsson; Henrik Thorlacius
Journal:  Int J Colorectal Dis       Date:  2008-01-11       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.